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Aim. Headache is one of the most common diseases associated with Temporomandibular Disorders (TMDs).The aim of this study
was to evaluate, retrospectively, if headache influences TMD’s symptoms.Material and Methods. A total sample of 1198 consecutive
TMD patients was selected. After a neurological examination, a diagnosis of headache, according to the latest edition of the
International Classification of Headache Disorders, was performed in 625 subjects. Patients were divided into two groups based on
presence/absence of headache: GroupwithHeadache (GwH) andGroupwithoutHeadache (GwoH). Descriptive statistics andChi-
square index were performed. Results. Sociodemographic (gender, marital status, and occupation) and functional factors, occlusion
(occlusal and skeletal classes, dental formula, and occlusal abnormalities), and familiar pain did not show a statistically significant
correlation in either group. Intensity and frequency of neck pain, arthralgia of TMJ, and myalgia showed higher correlation values
in GwH. Conclusion. This study is consistent with previous literature in showing a close relationship between headache and TMD.
All data underlines that headache makes pain parameters more intense and frequent. Therefore, an early and multidisciplinary
treatment of TMDs should be performed in order to avoid the overlay of painful events that could result in pain chronicity.
1. Introduction
Temporomandibular Disorders (TMDs) involve alterations
of the temporomandibular joint (TMJ), masticatory muscles,
and related structures. Many of the clinical and instrumental
aspects of these disorders overlap with other medical dis-
ciplines like otology, neurology, psychiatry, and others [1].
Headache is one of themost common painful conditions; few
people are spared during their lifetime by at least one episode
of headache: it is estimated that about 90% of the general
population in a year suffer from at least a headache episode
[2]. Temporomandibular Disorders (TMDs) and headache
are closely related pathologies; prevalence of headache in
the dysfunctional population varies between 48% and 77%,
while in the general population the prevalence of headache
is around 45% [3–6]. Primary headaches as Migraine, ETTH
(Episodic Tension Type Headaches), and CDH (chronic
daily headaches) are more common in patients with TMD
symptoms compared to individuals without headache [7].
According to several studies, there is a strong correlation
between headache and other dysfunctional symptoms, such
as joint noise, pain duringmandibularmovement, pain in the
temporomandibular area, depression, anxiety, and poor sleep
quality [8].
Patients with headache and TMDs reported significantly
higher levels of pain and disability compared to patients with
only TMDs [9, 10].
The aim of this study was to evaluate if headache influ-
ences TMD’s symptoms; to investigate the research purpose
two homogeneous groups of TMD patients with and without
headache were analyzed.
2. Materials and Methods
2.1. Study Design. To address the research purpose, the
authors designed and implemented a retrospective cohort
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study, conducted at theDepartment of Oral andMaxillofacial
Sciences, at “Sapienza” University of Rome, and approved by
the institution review board (ref. number 2086/15).
The study sample was composed of a population derived
from patients presenting at the University’s Department for
TMDs management in an interval of time between January
2011 and December 2013, according to the inclusion and
exclusion criteria.
Subjects eligible for study inclusion had TMD diagnosis,
based on Diagnostic Criteria for Temporomandibular Disor-
ders (DC/TMD) [11], and provided signed informed consent
according to the World Medical Association’s Declaration of
Helsinki.
Patients were excluded from enrollment to the study, if
they had an uncontrolled systemic disease, missing medical
records, a history of mental disorders, or refused to enroll to
this study.
Subjects with coexisting/history of drug administration,
physiotherapy, and splint therapy for previous headache
treatment were excluded from the study.
2.2. Headache Assessment. A total sample of 1198 TMD
patients was selected. Presence of headache was analyzed
using both clinical parameters recorded on patient’s medical
charts and answers given by patient on the DC/TMD Symp-
tom Questionnaire.
Headache was found in 894 (75%) patients while in 304
(25%) was excluded.
In order to differentiate headache and perform a correct
diagnosis to exclude false positives, all patients positive
for headache were invited to undergo a neurological visit
with a neurologist specialized in the diagnosis of primary
headache according to the latest edition of the International
Classification of Headache Disorders (ICDH-III) [12].
After the neurological visit, in accord with ICHD-III, a
diagnosis of headache was performed in 625 patients.
Two hundred and sixty-nine patients were excluded from
the study: in particular, 191 subjects did not undergo the
neurological examination and 78 were found to be affected
from other neurological diseases, such as atypical facial pain
and cranial neuralgia.
2.3. Study Variables. The total sample of TMD patients
composed by 929 (78% of initial TMD sample) was divided
into two groups based on presence/absence of headache in
TMDs:
(1) Group with Headache (GwH), composed of 𝑛 = 625
(67.3% of TMD sample).
(2) Group without Headache (GwoH), composed of 𝑛 =
304 (32.7% of TMD sample).
Based on the analysis of themedical charts, five categories
of variables were considered:
(1) Sociodemographic factors (gender, age, marital sta-
tus, and occupation).
(2) Types of pain (arthralgia, muscle pain, headache,
familiar pain, neck pain, and emotional strain).
(3) Functional aspects (maximum spontaneous mouth
opening, expressed in mm).
(4) Occlusion (occlusal and skeletal class, dental formula,
occlusal abnormalities, and parafunctions).
(5) Diagnostics (muscle pain,myofascial pain,myofascial
painwith referral, TMJ pain,DiscDisplacement (DD)
with Reduction (R), Subluxation, DD with Reduc-
tion (R) and intermittent Mouth Opening Limitation
(MOL), DD without R with MOL, DD without R
without MOL, and degenerative joint disease).
Age was evaluated through a qualitative scale with
the following subdivisions: 0–15 childhood, 16–25 adoles-
cents/young adults, 26–40 adults, 41–50 middle-aged adults,
51–60 mature/older adults, 61–70 seniors, and 71+ elders.
The type of painwas evaluated for each individual patient,
considering anatomical position and intensity.
Pain intensity (cephalic, joint, muscle, and cervical pain)
was evaluated utilizing the Verbal Numeric Scale (VNS)
[13], which uses numeric values (0–100) to decipher the
intensity of pain, with the following division into classes of
pain intensity: 0 (no pain); 0–20 (slight and episodic pain);
20–50 (moderate pain); 50–80 (severe pain); and 80–100
(very severe pain).
Familiar pain was identified as the pain that prompted the
patient to the gnathological visit.
Emotional strain was assessed using the DC self-
evaluation questionnaire system and investigating the pres-
ence/absence of stress time beyond the norm during the
previous six months.
Maximum spontaneous mouth opening was evaluated
using numeric values in millimeters (mm) according to the
parameters set by the DC/TMD; then the value obtained
for each patient was converted into a qualitative functional
measurement, using the following division into classes: 0–20
(severe restriction), 21–30 (limited), 31–40 (mild limitation),
41–50 (normal), and 50+ (laxity).
Presence/absence of parafunctional habits was assessed
through the patient’smedical history and a clinical evaluation
of the morphological-functional state of the skeletal muscles
and of the dental-periodontal tissues.
2.4. Statistical Analysis. The prevalence of headache in
patients with TMDswas analyzed proportionally among sub-
jects from the Total Dysfunctional Sample (TDS) who tested
positive to cephalic pain for the entire period considered
(2011–2013). Confidence intervals were set at 95% to obtain
a precise estimate of headache prevalence in the sample. The
Chi-square index was performed to evaluate the significance
of statistical correlation among the variables considered, with
a level of statistical significance 𝛼 = 0.05.
3. Results
Sociodemographic (gender, marital status, and occupation)
and functional factors, occlusion (occlusal and skeletal
classes, dental formula, and occlusal abnormalities), and
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Table 1: Absolute frequency (𝑁) and percentage (%) values of headache types in Group with Headache (GwH), according to the ICHD-III.
ETTH: Episodic Tension Type Headache; CTTH: Chronic Tension Type Headache; MwA: Migraine with Aura; MwoA: Migraine without
Aura; CM: Chronic Migraine; TMD Headache: Headache attributed to TMD; Neck Headache: Headache attributed to disorder of Neck.
ICHD-III diagnosis 𝑁 (%) Cl95%
ETTH 153 (24.5%) Cl95%: 21.1%–27.9%
CTTH 54 (8.6%) Cl95%: 6.6%–10.6%
MwA 51 (8.2%) Cl95%: 6.1%–10.3%
MwoA 187 (29.9%) Cl95%: 26.3–3.5%
CM 136 (21.8%) Cl95%: 18.6%–25.0%
TMD Headache 32 (5.1%) Cl95%: 3.4%–6.8%
Neck Headache 12 (1.9%) Cl95%: 0.9%–2.9%
Table 2: Absolute frequency (𝑁) and percentage (%) values of age intervals in TotalDysfunctional Sample (TDS) and inGroupwithHeadache
(GwH) and Group without Headache (GwoH).
Age TMD sample GwH GwoH
𝑁 (%) Cl95% 𝑁 (%) Cl95% 𝑁 (%) Cl95%
0–15 11 (1.2%) Cl95%: 0.5%–1.9% 10 (1.6%) Cl95%: 0.6%–2.6% 1 (0.3%) Cl95%: 0.6%–2.6%
16–25 215 (23.1%) Cl95%: 20.7%–25.8% 142 (22.7%) Cl95%: 19.7%–25.7% 73 (24.0%) Cl95%: 0.6%–2.6%
26–40 235 (25.3%) Cl95%: 22.5%–27.9% 182 (29.1%) Cl95%: 26.1%–32.1% 53 (17.4%) Cl95%: 0.6%–2.6%
41–50 211 (22.7%) Cl95%: 20.1%–25.3% 166 (26.6%) Cl95%: 23.6%–29.6% 45 (14.8%) Cl95%: 0.6%–2.6%
51–60 141 (15.2%) Cl95%: 19.9%–17.5% 72 (11.5%) Cl95%: 9.5%–13.5% 69 (22.7%) Cl95%: 0.6%–2.6%
61–70 88 (9.5%) Cl95%: 7.7%–11.3% 37 (5.9%) Cl95%: 4.1%–7.7% 51 (16.8%) Cl95%: 0.6%–2.6%
70+ 28 (3.0%) Cl95%: 2.0%–4.0% 6 (2.6%) Cl95%: 1.4%–3.8% 12 (4.0%) Cl95%: 0.6%–2.6%
familiar pain did not show a statistically significant correla-
tion in either group.
In the TMD sample, headache prevalence was found to
be 67.3% (𝑁 = 625, CI95%: 64.3%–70.3%). In GwH, pain
score was 70 ± 24.4 VNS and 78% of patients (𝑁 = 487,
Cl95%: 74.6%–81.4%) showed VNS values higher than 50.
According to the ICHD-III, the types of headache diag-
nosed by the neurologist were in order of decreasing fre-
quency: Migraine without Aura (MwoA), Episodic Tension
Type Headache (ETTH), Chronic Migraine (CM), Chronic
Tension Type Headache (CTTH), Migraine with Aura
(MwA), Headache attributed to TMD (TMDHeadache), and
Headache attributed to disorder of Neck (Neck Headache)
(Table 1). Statistically significant differences were observed
in age classes between GwH and GwoH (Table 2) and in
their graphic trends (Figure 1). In GwH, the age classes most
frequently involved were 26–40 (𝑁 = 182) and 41–50 (𝑁 =
166). Patients of 16–25 (𝑁 = 73) and 51–60 (𝑁 = 69)
were themost represented in GwoH. All variables considered
showed higher values in GwH, while absence of pain was
more frequent in GwoH (Table 3; Figure 2).
The statistical analysis demonstrated a significant correla-
tion between presence of joint pain and headache (𝑋-squared
value = 24.3216) and between intensity of same-side joint
and cephalic pain (𝑋-squared value = 59.1496).The following
associations were found to be statistically significant: inten-
sity of muscular pain and ipsilateral headache; neck pain and
headache (Table 4). Emotional strain (GwH = 45%, CI95%:
41.1%–48.9%; GwoH = 27%, Cl95%: 22.1%–31.9%) and para-
functional habits (GwH = 73%, CI95%: 69.6%–76.4%; GwoH
= 52% CI95%: 46.4%–57.6%) showed higher values in GwH,
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Figure 1: Line chart of frequency distribution for age intervals
in Group with Headache (GwH) and Group without Headache
(GwoH).
with a correlation between headache and parafunctions (𝑋-
squared values = 42.7842) (Table 4; Figure 2).
DC/TMD pathologies such as myalgia, arthralgia, and
reducible disc dislocation were found to be more frequent
in GwH. TMJ pain, Disc Displacement with Reduction,
and myofascial pain showed a correlation between the side
of pathology and ipsilateral headache, although with lower
correlation coefficients. Instead, DD with Reduction and
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Table 3: Absolute frequency (𝑁) and percentage (%) values of prevalence of painful variables of cranium-facial districts (presence of joint
pain, muscle pain, and neck pain) in Group with Headache (GwH) and Group without Headache (GwoH). TMJ: temporomandibular joint.
VNS: Verbal Numeric Scale (0–100).
VNS
TMJ pain
GwH GwoH
𝑁 (%) Cl95% 𝑁 (%) Cl95%
0 93 (14.9%) Cl95%: 12.2%–17.6% 89 (29.3%) Cl95%: 24.2%–34.4%
1–20 76 (12.2%) Cl95%: 14.7%-14.7% 42 (13.8%) Cl95%: 10%–17.6%
21–50 112 (17.9%) Cl95%: 14.9%–20.9% 57 (18.8%) Cl95%: 14.4%–23.2%
51–80 234 (37.4%) Cl95%: 33.6%–41.7% 80 (26.3%) Cl95%: 21.4%–31.2%
81–100 110 (17.6%) Cl95%: 4.6%–20.6% 36 (11.8%) Cl95%: 8.2%–15.4%
VNS
Muscle pain
GwH GwoH
𝑁 (%) Cl95% 𝑁 (%) Cl95%
0 231 (37%) Cl95%: 33.2%–40.8% 166 (54.6%) Cl95%: 49.0%–60.2%
1–20 45 (7.2%) Cl95%: 5.2%–9.2% 26 (14.8%) Cl95%: 10.9%–18.7%
21–50 120 (19.2%) Cl95%: 16.1%–22.3% 45 (8.6%) Cl95%: 5.5%–11.7%
51–80 51 (8.2%) Cl95%: 6.1%–10.3% 22 (14.8%) Cl95%: 10.9%–18.7%
81–100 178 (28.4%) Cl95%: 24.9%–31.9% 45 (7.2%) Cl95%: 4.3%–10.1%
VNS
Neck pain
GwH GwoH
𝑁 (%) Cl95% 𝑁 (%) Cl95%
0 159 (25%) Cl95%: 21.7%–28.3% 160 (52.6%) Cl95%: 47%–58.2%
1–20 39 (6%) Cl95%: 4.1%–7.9% 14 (4.6%) Cl95%: 2.3%–6.9%
21–50 85 (14%) Cl95%: 11.3%–16.7% 33 (10.9%) Cl95%: 7.4%–14.4%
51–80 169 (27%) Cl95%: 23.5%–30.5% 67 (22%) Cl95%: 17.4%–26.6%
81–100 173 (28%) Cl95%: 24.5%–31.5% 30 (9.9%) Cl95%: 6.6%–13.3%
VNS
Headache
GwH
𝑁 (%) Cl95%
1–20 50 (8%) Cl95%: 5.9%–10.1%
21–50 88 (14%) Cl95%: 11.3%–16.7%
51–80 231 (37%) Cl95%: 33.2%–40.8%
81–100 256 (41%) Cl95%: 37.2%–44.8%
intermittent Mouth Opening Limitation were more common
in GwoH, although with lower correlation coefficients (𝑋2
value = 5.1456, df = 1, 𝜒2
1,0.95
= 3.84). Other diseases
demonstrated lower or insignificant correlation (Table 5).
4. Discussion
Headache appeared to be the most common symptom of
diseases accompanying TMD [13]. Ciancaglini and Radaelli
[14] suggested that 70% of headache patients had also a
clinical confirmation of TMD. On the other hand, TMDs
were also prevalent in subjects with headache [15, 16]. In the
population of our study, headache prevalence was found to
be of 67.3% (Cl95%: 64.3%–70.3%), in agreement with current
literature.
Other studies [16–18] showed how primary headaches
are more frequent in the dysfunctional patients compared
to the control group. According to our findings, MwoA and
ETTH were the most frequently reported primary headaches
associated with TMD patients, with a prevalence of 29.9%
(𝑁 = 187, Cl95%: 26.3%–3.5%) and 24.5% (𝑁 = 153, Cl95%:
21.1%–27.9%), respectively.
In the dysfunctional Group with Headache (GwH), the
peak age group was “30–40” (Figure 1). These results are
in agreement with another study on headache and TMD
that showed a higher prevalence between 20 and 40 years
of age with a subsequent tendency to decrease [19]. On the
other hand, two higher peaks were found in GwoH: one
between 16 and 25 yrs and another one in the 40–60-year
group (Figure 1).
The different behavior betweenGwH andGwoH could be
explained by the fact that headache determines an increased
central sensitization to pain and an exacerbation of pain
symptoms in the craniocervical-mandibular joint, thus moti-
vating patients to seek treatment for previously existing
gnathologic problems [20].
Central sensitization is characterized by pain hypersensi-
tivity, particularly dynamic tactile allodynia, secondary punc-
tate or pressure hyperalgesia, aftersensations, and enhanced
temporal summation [20, 21].
In addition, absence of severely painful symptoms might
induce patients to underestimate dysfunctional problems,
which could become discernible only in the chronic phase,
explaining the second age peak (40–60 years) in GwoH.
Pain Research and Management 5
Table 4: 𝑋-squared value of correlation between presence and intensity of headache and presence and intensity of muscle, joint, and/or
cervical ipsilateral pain and between presence of headache and presence of parafunctional habits.
𝑋-squared presence 𝑋-squared intensity
Ipsilateral headache and joint pain 24.3216 59.1496
𝜒2
1,0.95
= 3.84 𝜒2
9,0.95
= 16.92
Ipsilateral headache and muscle pain 22.1273 27.4131
𝜒2
1,0.95
= 3.84 𝜒2
9,0.95
= 16.92
Ipsilateral headache and cervical pain 97.3326 81.3128
𝜒2
1,0.95
= 3.84 𝜒2
9,0.95
= 16.92
Parafunctional habits 42.7842 —
𝜒2
1,0.95
= 3.84
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Figure 2: Percentage (%) values of prevalence of painful variables
(joint pain for individual TMJ, presence of joint pain, muscle pain,
and neck pain), emotional tension in the previous 6 months, and
parafunctional habits in Group with Headache (GwH) and Group
without Headache (GwoH).
Several studies [22, 23] showed a correlation between
frequency and intensity of headaches and presence of TMDs.
Patients with headache and TMDs reported statistically
significant higher levels of pain and disability compared
to patients with only TMDs [10]. This may explain why
headache was found to be more frequent and intense in
dysfunctional patients compared to the control population
[24]. Furthermore, debilitating headache (VNS score > 50)
was found in the majority (78% Cl95%: 75%–81%) of dysfunc-
tional patients in our study. These results suggest that when
patients report a severe headache, a clinical assessment of
themorphofunctional state of temporomandibular joints and
masticatorymuscles should be performed in order to exclude
the presence of TMDs. Our research found that painful
pathologies of the craniofacial region are more frequent and
intense in patients who suffer simultaneously from headache.
Compared to GwoH, the increase in pain in GwH could also
be explained by the greater central and peripheral nervous
sensitivity that characterizes patients with headache. In dys-
functional patients, there is a significant association between
presence of painful sites during palpation in areas innervated
by the trigeminal nerve and headache frequency [25–27].
According to the pain adaptation theory [28], different types
of pain tend to reinforce each other. In support of this
hypothesis, data showed a direct proportionality between
intensity of pain and headache (Table 3). This finding is
also confirmed by analysis of pathologies considering the
side of the body involved: when dysfunctional pain (joint;
muscle) and/or cervical pain was located on the same side
of headache, pain tended to be directly proportional to
headache (Table 4). In GwH, the kind of painmost frequently
associated with headache, regarding frequency, intensity, and
statistical correlation, was found to be neck pain (Tables 3 and
4). Some researchers have evaluated the relationship between
cervical stimulation and onset of headache, in particular the
presence of cervical trigger points ipsilateral to headache
site [29, 30]. This phenomenon is explained by the presence
of cervical nerve afferents in the trigeminal nerve nuclei
[31].
Emotional tension and parafunctions weremore frequent
in GwH compared to GwoH, respectively, 18.1% (Cl95%:
12.3%–23.9%) and 21.7% (Cl95%: 19.7%–23.7%) (Figure 2).
A correlation was also found between the presence of
parafunctions and headache (𝑥-square values = 42.7842)
(Table 4). Independent of mechanism and direction of the
association between parafunctions and headache, our data
showed similar results of other studies that have underlined
how the presence of parafunctions may favour headache
presence and vice versa [32]. In the two groups analyzed,
there was an even distribution of DC/TMD diseases, with
the most frequent being joint pain, which was present in
70–80% of patients. In TMD patients, a higher prevalence of
joint problems than muscular problems was found (Table 5).
Data that emerged in this study showed that headache has
a different relationship with muscle pain compared to joint
pain.
According to our findings, headache was found to be
related to muscle pain with respect to frequency, while
it is found to be associated with joint pain with respect
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to intensity (𝑥-square = 27.4131 versus 𝑥-square values =
59.1496) (Table 4). In particular, joint pain seems to exac-
erbate headache more than muscle pain. Finally, it can be
assumed that in a dysfunctional patient the reduction of
headache intensity and frequency can be achieved by the
improvement of joint and muscle function, respectively.
5. Conclusion
This study is consistent with previous literature in showing a
close relationship between headache and TMD. Data under-
lines that headache makes pain parameters more intense and
frequent, complicating dysfunctional diseases both in the
diagnostic phase and in treatment.Therefore, it is desirable to
perform an early andmultidisciplinary treatment of TMDs in
order to avoid the overlay of painful events that could result
in pain chronicity.
Conflicts of Interest
The authors declare that there are no conflicts of interest.
References
[1] C. Di Paolo, G. D. Costanzo, F. Panti et al., “Epidemiological
analysis on 2375 patients with TMJ disorders: basic statistical
aspects,”Annali di Stomatologia, vol. 20, no. 4, pp. 161–169, 2013.
[2] C. Angelini and L. Battistin, Neurologia Clinica, chapter 9,
Society Esculapio, 2014.
[3] A. G. Glaros, D. Urban, and J. Locke, “Headache and temporo-
mandibular disorders: evidence for diagnostic and behavioural
overlap,” Cephalalgia, vol. 27, no. 6, pp. 542–549, 2007.
[4] S. Mitrirattanakul and R. L. Merrill, “Headache impact in
patients with orofacial pain,” Journal of the American Dental
Association, vol. 137, no. 9, pp. 1267–1274, 2006.
[5] A. D’Urso, E. Serritella, D. Tolevski Meshkova, G. Falisi, and
C. Di Paolo, “Headache and temporo mandibular disorders:
epidemiological assessment,” Minerva Stomatologica, vol. 65,
no. 2, pp. 85–96, 2016.
[6] L. J. Stovner, K. Hagen, R. Jensen et al., “The global burden
of headache: a documentation of headache prevalence and
disability worldwide,” Cephalalgia, vol. 27, no. 3, pp. 193–210,
2007.
[7] D. A. G. Gonc¸alves, M. E. Bigal, L. C. F. Jales, C. M. Cam-
paris, and J. G. Speciali, “Headache and symptoms of tem-
poromandibular disorder: an epidemiological study: research
submission,” Headache, vol. 50, no. 2, pp. 231–241, 2010.
[8] N. Caspersen, J. R. Hirsvang, L. Kroell et al., “Is there a relation
between tension-type headache, temporomandibular disorders
and sleep?” Pain Research and Treatment, vol. 2013, Article ID
845684, 6 pages, 2013.
[9] S. B. Graff-Radford, “Temporomandibular disorders and
headache,” Dental Clinics of North America, vol. 51, no. 1, pp.
129–144, 2007.
[10] A. G. Glaros, A. H. Hanson, and C. C. Ryen, “Headache
and oral parafunctional behaviors,” Applied Psychophysiology
Biofeedback, vol. 39, no. 1, pp. 59–66, 2014.
[11] E. Schiffman, R. Ohrbach, E. Truelove et al., “Diagnostic
Criteria for Temporomandibular Disorders (DC/TMD) for
Clinical and Research Applications: recommendations of the
International RDC/TMDConsortiumNetwork∗ and Orofacial
Pain Special Interest Group,” Journal of Oral & Facial Pain and
Headache, vol. 28, no. 1, pp. 6–27, 2014.
[12] International Headache Society,The International Classification
of Headache Disorders, Cephalalgia, 3rd edition, 2013.
[13] D. M. Young, J. C. Mentes, and M. G. Titler, “Acute pain
management protocol,” Journal of Gerontological Nursing, vol.
25, article 10, 1999.
[14] R. Ciancaglini and G. Radaelli, “The relationship between
headache and symptoms of temporomandibular disorder in the
general population,” Journal of Dentistry, vol. 29, no. 2, pp. 93–
98, 2001.
[15] D. A. G. Gonc¸alves, M. E. Bigal, L. C. F. Jales, C. M. Camparis,
and J. G. Speciali, “Headache and symptoms of temporo-
mandibular disorder: an epidemiological study,”Headache, vol.
50, no. 2, pp. 231–241, 2010.
[16] V. Ballegaard, P. Thede-Schmidt-Hansen, P. Svensson, and
R. Jensen, “Are headache and temporomandibular disorders
related? A blinded study,” Cephalalgia, vol. 28, no. 8, pp. 832–
841, 2008.
[17] C. Di Paolo, A. Di Nunno, N. Vanacore, and G. Bruti,
“ID migraine questionnaire in temporomandibular disorders
with craniofacial pain: a study by using a multidisciplinary
approach,” Neurological Sciences, vol. 30, no. 4, pp. 295–299,
2009.
[18] M. Troeltzsch, M. Troeltzsch, R. J. Cronin, A. H. Brodine, R.
Frankenberger, and K. Messlinger, “Prevalence and association
of headaches, temporomandibular joint disorders, and occlusal
interferences,” Journal of Prosthetic Dentistry, vol. 105, no. 6, pp.
410–417, 2011.
[19] D. Manfredini, L. Guarda-Nardini, E. Winocur, F. Piccotti,
J. Ahlberg, and F. Lobbezoo, “Research diagnostic criteria
for temporomandibular disorders: a systematic review of axis
i epidemiologic findings,” Oral Surgery, Oral Medicine, Oral
Pathology, Oral Radiology and Endodontology, vol. 112, no. 4, pp.
453–462, 2011.
[20] A. Latremoliere and C. J. Woolf, “Central sensitization: a
generator of pain hypersensitivity by central neural plasticity,”
Journal of Pain, vol. 10, no. 9, pp. 895–926, 2009.
[21] J. Nijs, C. Paul van Wilgen, J. Van Oosterwijck, M. van
Ittersum, and M. Meeus, “How to explain central sensitization
to patients with ‘unexplained’ chronic musculoskeletal pain:
practice guidelines,”ManualTherapy, vol. 16, no. 5, pp. 413–418,
2011.
[22] J. T. Kemper Jr. and J. P. Okeson, “Craniomandibular disorders
and headaches,” The Journal of Prosthetic Dentistry, vol. 49, no.
5, pp. 702–705, 1983.
[23] C. Pettengill, “A comparison of headache symptom between
two groups: a TMD group and a general dental practice group,”
Cranio, vol. 17, no. 1, pp. 64–69, 1999.
[24] D. Bevilaqua Grossi, R. B. Lipton, and M. E. Bigal, “Temporo-
mandibular disorders and migraine chronification,” Current
Pain and Headache Reports, vol. 13, no. 4, pp. 314–318, 2009.
[25] H. Mørk, M. Ashina, L. Bendtsen, J. Olesen, and R. Jensen,
“Possible mechanisms of pain perception in patients with
episodic tension-type headache. A new experimental model of
myofascial pain,” Cephalalgia, vol. 24, no. 6, pp. 466–475, 2004.
[26] L. Bendtsen, R. Jensen, and J. Olesen, “Qualitatively altered
nociception in chronic myofascial pain,” Pain, vol. 65, no. 2-3,
pp. 259–264, 1996.
8 Pain Research and Management
[27] R. Jensen, B. K. Rasmussen, B. Pedersen, and J. Olesen, “Muscle
tenderness and pressure pain thresholds in headache. A popu-
lation study,” Pain, vol. 52, no. 2, pp. 193–199, 1993.
[28] M. S. Gold and G. F. Gebhart, “Nociceptor sensitization in pain
pathogenesis,” Nature Medicine, vol. 16, no. 11, pp. 1248–1257,
2010.
[29] D. H. Watson and P. D. Drummond, “Head pain referral
during examination of the neck in migraine and tension-type
headache,” Headache, vol. 52, no. 8, pp. 1226–1235, 2012.
[30] C. Ferna´ndez-De-Las-Pen˜as, M. L. Cuadrado, and J. A. Pareja,
“Myofascial trigger points, neck mobility and forward head
posture in unilateral migraine,” Cephalalgia, vol. 26, no. 9, pp.
1061–1070, 2006.
[31] T. Bartsch and P. J. Goadsby, “The trigeminocervical complex
andmigraine: current concepts and synthesis,”Current Pain and
Headache Reports, vol. 7, no. 5, pp. 371–376, 2003.
[32] R. Jensen and J. Olesen, “Initiating mechanisms of experimen-
tally induced tension-type headache,” Cephalalgia, vol. 16, no. 3,
pp. 175–182, 1996.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
